-
A team from The Ohio State University Wexner Medical Center and College of Medicine has created a new database in an effort to help researchers study Alzheimer’s disease. A study on the database, called ssREAD, was published in “Nature Communications” in June. It is freely searchable and contains 1,053 samples with 67 Alzheimer’s disease related […]
-
Memory issues, confusion and personality changes are thought to be early symptoms of Alzheimer’s, but a new study shows financial decline in older adults can be another early indicator. Older adults who eventually were diagnosed with Alzheimer’s were 17.2% more likely to have fallen behind on mortgage payments, according to a new study from the […]
-
A new artificial intelligence (AI) tool using speech analysis is capable of identifying cognitive impairment in Spanish-speaking older adults. The algorithm, the subject of a recent study led by the University of Texas Southwestern Medical Center, could function as an early detection tool that “might aid in identifying” older adults at risk of developing dementia, […]
-
Senior living operators have spent recent years preparing for the arrival of the Baby Boomer generation in their communities, and time is of the essence for memory care operators who must transform operations to prepare for the latest generation. From sales and marketing evolving to attract new residents and connect with families, to changing memory […]
-
A new Alzheimer’s treatment is showing promising initial results in early clinical trials. Published in a study in Nature Medicine, researchers from Western University, Stanford University and the University of California, San Francisco, have evaluated the effectiveness of a drug that is for now called LM11A-31, which targets a specific neurotrophin receptor. According to the […]
-
Entrepreneur and philanthropist Bill Gates believes the healthcare industry is “at a tipping point on Alzheimer’s.” That’s what Gates told Scientific American in a recent interview. Gates noted that, at the beginning of last year, the therapeutic pipeline for Alzheimer’s disease encompassed 187 clinical trials and contained 141 therapeutic drug formulations. Through Gates Ventures, Gates’ […]
-
Sometimes solving challenges in the memory care sector can feel like climbing Mount Everest—just ask Anthem Memory Care CEO Isaac Scott. Like climbing the famous summit, memory care operators have quite a climb ahead of them, in several ways. One big one is the remainder of this year, which will be a test of operational […]
-
Memory care demand is expected to grow in the years ahead – but operators must evolve for the future if they hope to see it. To help attract new residents in the months and years ahead, operators are both focusing on the real estate and the knowledge of treating cognitive decline. That is resulting in […]
-
Brookdale (NYSE: BKD) is in the process of rolling out its HealthPlus to more than 80 additional communities throughout this year. The implementation of the program will have an outsized impact on memory care, according to Kim Elliott, senior vice president and chief nursing officer at Brookdale. Brookdale has deployed HealthPlus in about 50 communities […]
-
A hormone found in the brain of every human could be used as a treatment to delay the proliferation of Alzheimer’s in its early stages. Researchers with the University of Dundee in Scotland found that a small part of an appetite-suppressing hormone known as leptin could reduce the effects of the two harmful proteins in […]